• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声在恶性卵巢肿瘤的筛查、分期和监测中的特殊作用:与其他诊断成像方法的区别。

The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging.

机构信息

Ultrasound Unit, Department of Gynecology and Obstetrics, University Hospital of Basel, Basel, Switzerland,

出版信息

Arch Gynecol Obstet. 2014 Mar;289(3):491-8. doi: 10.1007/s00404-013-3081-8. Epub 2013 Nov 20.

DOI:10.1007/s00404-013-3081-8
PMID:24253338
Abstract

Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging around 40%. A crucial factor influencing the prognosis is early detection of a suspicious mass and referral to a gynecologic oncology center for further diagnosis, staging and debulking surgery. Here, we present the different imaging methods ultrasound (US), magnetic resonance imaging, computer tomography (CT) and 18F-fluoro-deoxyglucose positron emission tomography (PET)/CT that are used for the characterization, diagnosis, staging and surveillance of ovarian cancer. In this review, we focus on US and discuss in detail the advantages and the limitations, as well as the appropriate indications for each of the individual imaging techniques.

摘要

卵巢癌是最具侵袭性的妇科恶性肿瘤,5 年生存率约为 40%。影响预后的一个关键因素是早期发现可疑肿块,并转至妇科肿瘤中心进一步诊断、分期和肿瘤细胞减灭术。本文介绍了不同的影像学方法,包括超声(US)、磁共振成像(MRI)、计算机断层扫描(CT)和 18F-氟脱氧葡萄糖正电子发射断层扫描(PET)/CT,用于卵巢癌的特征描述、诊断、分期和监测。在本篇综述中,我们重点介绍了 US,并详细讨论了其优势和局限性,以及每种影像学技术的适用指征。

相似文献

1
The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging.超声在恶性卵巢肿瘤的筛查、分期和监测中的特殊作用:与其他诊断成像方法的区别。
Arch Gynecol Obstet. 2014 Mar;289(3):491-8. doi: 10.1007/s00404-013-3081-8. Epub 2013 Nov 20.
2
Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.原发性卵巢癌的诊断和分期:PET/CT、多普勒超声与 CT 或 MRI 的相关性。
Gynecol Oncol. 2010 Mar;116(3):389-94. doi: 10.1016/j.ygyno.2009.10.059. Epub 2009 Nov 18.
3
Ovarian cancer: detection and radiologic staging.卵巢癌:检测与放射学分期
Clin Obstet Gynecol. 2009 Mar;52(1):73-93. doi: 10.1097/GRF.0b013e3181961625.
4
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.磁共振成像(MRI)、计算机断层扫描(CT)和正电子发射断层扫描/计算机断层扫描(PET/CT)在卵巢癌检测和附件病变特征中的应用。
AJR Am J Roentgenol. 2010 Feb;194(2):311-21. doi: 10.2214/AJR.09.3522.
5
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.盆腔肿块疑似卵巢癌患者的 PET/CT 分期。
Gynecol Oncol. 2013 Dec;131(3):694-700. doi: 10.1016/j.ygyno.2013.08.020. Epub 2013 Aug 27.
6
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.对比增强磁共振成像与正电子发射断层扫描/计算机断层扫描联合评估卵巢肿块
Invest Radiol. 2014 Aug;49(8):524-31. doi: 10.1097/RLI.0000000000000050.
7
FDG-PET/CT as a molecular biomarker in ovarian cancer.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为卵巢癌的分子生物标志物。
Cancer Biomark. 2010;8(4-5):167-75. doi: 10.3233/CBM-2011-0219.
8
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.18F-FDG PET/CT在卵巢病变特征诊断及卵巢癌分期中的诊断准确性:与经阴道超声、计算机断层扫描及组织学的相关性
Nucl Med Commun. 2007 Aug;28(8):589-95. doi: 10.1097/MNM.0b013e3281afa256.
9
Imaging techniques for the evaluation of ovarian cancer.卵巢癌的影像学评估技术。
Best Pract Res Clin Obstet Gynaecol. 2014 Jul;28(5):697-720. doi: 10.1016/j.bpobgyn.2014.04.006. Epub 2014 Apr 30.
10
Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography.
J Comput Assist Tomogr. 2004 Jul-Aug;28(4):505-16. doi: 10.1097/00004728-200407000-00011.

引用本文的文献

1
A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.一种基于尿液蛋白质组学的新型分类器用于鉴别卵巢良恶性肿瘤
Front Cell Dev Biol. 2021 Aug 30;9:712196. doi: 10.3389/fcell.2021.712196. eCollection 2021.
2
Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses.术前炎症标志物用于鉴别上皮性卵巢癌与卵巢良性肿块的效用。
J Cancer. 2021 Mar 5;12(9):2687-2693. doi: 10.7150/jca.51642. eCollection 2021.
3
Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses.
炎症标志物鉴别卵巢良恶性肿块的诊断准确性
J Cancer. 2018 Mar 8;9(7):1165-1172. doi: 10.7150/jca.23606. eCollection 2018.
4
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.瑞士遗传性乳腺癌/卵巢癌和林奇综合征的癌症易感性级联筛查:研究方案
JMIR Res Protoc. 2017 Sep 20;6(9):e184. doi: 10.2196/resprot.8138.
5
Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.术前血小板计数在附件肿瘤诊断中的效用。
Tumour Biol. 2016 Sep;37(9):12079-12087. doi: 10.1007/s13277-016-5090-2. Epub 2016 May 20.
6
Simple laboratory score improves the preoperative diagnosis of adnexal mass.简易实验室评分可改善附件包块的术前诊断。
Tumour Biol. 2016 Apr;37(4):4343-9. doi: 10.1007/s13277-015-4280-7. Epub 2015 Oct 23.
7
Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study.卵巢交界性肿瘤与术中诊断的诊断困境:术前人附睾蛋白4检测和风险评估模型(ROMA)评分能否提高冰冻切片诊断的准确性?一项多中心病例对照研究。
Biomed Res Int. 2014;2014:803598. doi: 10.1155/2014/803598. Epub 2014 Nov 5.
8
Murine model for non-invasive imaging to detect and monitor ovarian cancer recurrence.用于检测和监测卵巢癌复发的非侵入性成像小鼠模型。
J Vis Exp. 2014 Nov 2(93):e51815. doi: 10.3791/51815.
9
In 2014, can we do better than CA125 in the early detection of ovarian cancer?2014年,在卵巢癌的早期检测方面,我们能否比CA125做得更好?
World J Biol Chem. 2014 Aug 26;5(3):286-300. doi: 10.4331/wjbc.v5.i3.286.